Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Townsend

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 2, 2016
MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyondRounak Nassirpour, Dominic Raj, Raymond Townsend, et al.
American Journal of Nephrology|October 10, 2002
Management of chronic kidney disease in an academic primary care clinicAjay Israni, Cynthia Korzelius, Raymond Townsend, et al.
Journal of the American College of Cardiology|August 31, 2019
Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art ReviewJulio A Chirinos, Patrick Segers, Timothy Hughes, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 7, 2011
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trialKeith C Ferdinand, James Pool, Richard Weitzman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort studyJason Roy, Nirav R Shah, G Craig Wood, et al.
Diabetes Care|May 1, 2007
Validation of steady-state insulin sensitivity indices in chronic kidney diseaseMichael F Crutchlow, Bruce Robinson, Binu Pappachen, et al.
American Journal of Hypertension|June 27, 2025
Ambulatory Blood Pressure Variability, Progression of Kidney Disease, and Cardiovascular Outcomes in the Chronic Renal Insufficiency CohortRushelle L Byfield, Rachel Zhang, Debbie L Cohen, et al.
American Heart Journal|December 25, 2015
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medicationsDavid E Kandzari, Kazuomi Kario, Felix Mahfoud, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 7, 2011
Blood pressure effects of naproxcinod in hypertensive patientsRaymond Townsend, Neville Bittar, Jeffrey Rosen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 17, 2022
Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatmentLama Ghazi, Fan Li, Xinyuan Chen, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 2, 2016
MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyondRounak Nassirpour, Dominic Raj, Raymond Townsend, et al.
American Journal of Nephrology|October 10, 2002
Management of chronic kidney disease in an academic primary care clinicAjay Israni, Cynthia Korzelius, Raymond Townsend, et al.
Journal of the American College of Cardiology|August 31, 2019
Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art ReviewJulio A Chirinos, Patrick Segers, Timothy Hughes, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 7, 2011
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trialKeith C Ferdinand, James Pool, Richard Weitzman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort studyJason Roy, Nirav R Shah, G Craig Wood, et al.
Diabetes Care|May 1, 2007
Validation of steady-state insulin sensitivity indices in chronic kidney diseaseMichael F Crutchlow, Bruce Robinson, Binu Pappachen, et al.
American Journal of Hypertension|June 27, 2025
Ambulatory Blood Pressure Variability, Progression of Kidney Disease, and Cardiovascular Outcomes in the Chronic Renal Insufficiency CohortRushelle L Byfield, Rachel Zhang, Debbie L Cohen, et al.
American Heart Journal|December 25, 2015
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medicationsDavid E Kandzari, Kazuomi Kario, Felix Mahfoud, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 7, 2011
Blood pressure effects of naproxcinod in hypertensive patientsRaymond Townsend, Neville Bittar, Jeffrey Rosen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 17, 2022
Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatmentLama Ghazi, Fan Li, Xinyuan Chen, et al.
Pageof 6